Amneal.com - We make healthy possible - Amneal Pharmaceuticals

Provided by Alexa ranking, amneal.com has ranked N/A in N/A and 110,800 on the world. amneal.com reaches roughly 28,770 users per day and delivers about 863,094 users each month. The domain amneal.com uses a Commercial suffix and it's server(s) are located in N/A with the IP number 98.129.229.110 and it is a .com domain.

WebLeading forward. Our leaders talk about how Amneal has diversified beyond generics to deliver value in complex retail generics, biosimilars, injectables, specialty and international. As of March 1, 2024, Amneal has three reportable business segments: 1) Generics (includes retail, injectables, biosimilars & international revenue), 2) Specialty ...

List of domain same IP 98.129.229.110

Search Results related to amneal.com on Search Engine

We make healthy possible - Amneal Pharmaceuticals
amneal.com

https://amneal.com/

WebLeading forward. Our leaders talk about how Amneal has diversified beyond generics to deliver value in complex retail generics, biosimilars, injectables, specialty and international. As of March 1, 2024, Amneal has three reportable business segments: 1) Generics (includes retail, injectables, biosimilars & international revenue), 2) Specialty ...

DA: 80 PA: 81 MOZ Rank: 3

Careers - Amneal Pharmaceuticals
amneal.com

https://amneal.com/careers/

WebWe also look for people who enjoy their work, want to grow with us, engage in our Responsibility commitments and make a difference for our company, our patients and our shareholders. We offer opportunities across our development, manufacturing, marketing and corporate support functions.

DA: 24 PA: 36 MOZ Rank: 82

Amneal Pharmaceuticals - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Amneal_Pharmaceuticals

WebAmneal Pharmaceuticals, Inc. is an American publicly traded generics and specialty pharmaceutical company. The company is headquartered in Bridgewater, New Jersey.

DA: 49 PA: 76 MOZ Rank: 67

Our Portfolio - Amneal Pharmaceuticals
amneal.com

https://amneal.com/products/our-portfolio/

WebIn the US, our portfolio of more than 270 medicines provides patients with more affordable access to quality medicines. Our growing Specialty portfolio meets important medical needs in neurology, endocrinology and other therapeutic categories.

DA: 80 PA: 50 MOZ Rank: 63

Our Story - Amneal Pharmaceuticals
amneal.com

https://amneal.com/about/our-story/

WebAmneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is a fully integrated global essential medicines company powered by a robust U.S. generics business and a growing branded business as well as deepening portfolios in institutional injectables, biosimilars and select international markets.

DA: 68 PA: 13 MOZ Rank: 25

About - Amneal Pharmaceuticals
amneal.com

https://amneal.com/about/

WebAbout. AboutWe challenge convention so healthy can be possible. Our Story. Amneal at-a-glance. Our Founders. Our Milestones. Our Purpose & Commitments. Our Culture. Rise, Lead, Succeed.

DA: 46 PA: 9 MOZ Rank: 62

Generic Products - Amneal Pharmaceuticals
amneal.com

https://amneal.com/products/our-portfolio/generic-products/

WebWe deliver quality, trustand value. Our generics business is among the largest in the U.S. We develop, manufacture and commercialize complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals across a broad range of therapeutic categories.

DA: 10 PA: 77 MOZ Rank: 97

Amneal at-a-glance - Amneal Pharmaceuticals
amneal.com

https://amneal.com/about/our-story/amneal-at-a-glance/

WebAmneal at-a-glance; Our Founders; Our Milestones; Our Purpose & Commitments; Our Culture. Rise, Lead, Succeed; Our Leadership. Executive Leadership; Board of Directors; Our Locations; Responsibility. The Amneal Patient Assistance Program; Product Donations; National and Local Philanthropy; Compliance and Ethics; Patient Community …

DA: 86 PA: 65 MOZ Rank: 49

Amneal Pharmaceuticals, Inc. - Amneal Launches PEMRYDI …
amneal.com

https://investors.amneal.com/news/press-releases/press-release-details/2024/Amneal-Launches-PEMRYDI-RTU-the-First-Ready-to-Use-Version-of-Important-Oncology-Injectable-Medicine/default.aspx

WebApr 16, 2024 · Novel 505(b)(2) presentation of a key injectable for treating non-squamous non-small cell lung cancer and malignant pleural mesothelioma, does not require reconstitution, dilution, or refrigeration Amneal plans to launch two to three branded oncology 505(b)(2) products per year going forward – this is the first of 2024 Amneal …

DA: 90 PA: 48 MOZ Rank: 24

Amneal Pharmaceuticals, Inc. - Amneal Announces 26 Generic …
amneal.com

https://investors.amneal.com/news/press-releases/press-release-details/2022/Amneal-Announces-26-Generic-New-Product-Launches-in-2022-and-First-InjectionLarge-Volume-Bag-Approval/default.aspx

WebDec 20, 2022 · Amneal Announces 26 Generic New Product Launches in 2022 and First Injection Large Volume Bag Approval. December 20, 2022. - 8 new product launches in Q4 closes out another successful year of innovation. - First approval of a large volume bag product signals further expansion of injectables business.

DA: 75 PA: 8 MOZ Rank: 84

Alexa Rank

GLOBAL RANK

110,800

Alexa Reach

0.0012700110

Page length

N/A

Alexa Rank Country N/A

N/A

Daily Unique Visitors

28,770

Monthly Unique Visitors

863,094

Vistor via Country

Country lang

Country code

Total visitor

Country

Country code

Total visitor

United States

184,616

Indonesia

144,396

Taiwan

46,952

United Kingdom

41,687

Brazil

37,717

Nigeria

32,970

Egypt

27,705

Hong Kong

26,152

Canada

26,152

Australia

22,786

Philippines

16,312

India

15,881

Malaysia

15,622

Spain

12,946

Germany

12,601

Mexico

12,083

France

11,393

Italy

10,530

Turkey

9,667

Iraq

8,804

Thailand

8,631

Netherlands

8,286

Israel

8,199

Cambodia

6,818

Algeria

5,265

Ireland

4,747

Romania

4,574

Jordan

4,229

Poland

4,057

Ghana

3,884

Argentina

3,711

South Africa

3,366

Belgium

3,021

Czechia

2,762

Ukraine

2,589

Japan

2,589

Morocco

2,503

South Korea

2,417

Lebanon

2,330

Saudi Arabia

2,244

Austria

2,158

Hungary

2,071

Sweden

1,985

Singapore

1,899

Pakistan

1,812

Bangladesh

1,726

Denmark

1,640

Greece

1,554

Alexa Traffic Graph

Alexa daily traffic trend graph

Alexa daily pageviews (percent) graph

Alexa Statistics Graph for www.nahklick.de

Alexa daily pageviews per user graph

Alexa time on site (in minutes) graph

Alexa bounce rate (percent) graph

Alexa search visits graph

SEOquake Zone

Title			Tips
Description			Tips
Keywords			Tips
Viewport			Tips
Icon
UTF-8

Mini site formation by Alexa Rank

MOZ Rank

DNS Record

Host	Type	Class	TTL	Extra
amneal.com	A	IN	60	Ip: 98.129.229.110
amneal.com	NS	IN	60	Target: ns-1382.awsdns-44.org
amneal.com	NS	IN	60	Target: ns-145.awsdns-18.com
amneal.com	NS	IN	60	Target: ns-1745.awsdns-26.co.uk
amneal.com	NS	IN	60	Target: ns-805.awsdns-36.net
amneal.com	SOA	IN	60	Mname: ns-1745.awsdns-26.co.uk Rname: awsdns-hostmaster.amazon.com Serial: 1 Refresh: 7200 Retry: 900 Expire: 1209600 Minimum-ttl: 86400
amneal.com	MX	IN	60	Pri: 10 Target: mxa-003ba101.gslb.pphosted.com
amneal.com	MX	IN	60	Pri: 10 Target: mxb-003ba101.gslb.pphosted.com
amneal.com	TXT	IN	60	Txt: MS=ms70756218 Entries_0: MS=ms70756218
amneal.com	TXT	IN	60	Txt: "v=spf1 ip4:45.79.128.24 ip4:23.239.15.18 ip4:174.128.40.224/27 ip4:208.80.200.0/21 ip4:52.170.85.198 ip4:40.118.163.33 ip4:54.240.43.16 include:spf-003ba101.pphosted.com include:spf.protection.outlook.com include:_spf.salesforce.cominclude:_spf.q4press.com include:40023361.spf10.hubspotemail.net include:docebosaas.com -all" Entries_0: "v=spf1 ip4:45.79.128.24 ip4:23.239.15.18 ip4:174.128.40.224/27 ip4:208.80.200.0/21 ip4:52.170.85.198 ip4:40.118.163.33 ip4:54.240.43.16 include:spf-003ba101.pphosted.com include:spf.protection.outlook.com include:_spf.salesforce.com Entries_1: include:_spf.q4press.com include:40023361.spf10.hubspotemail.net include:docebosaas.com -all"
amneal.com	TXT	IN	60	Txt: _globalsign-domain-verification=8Je578rUxg5R2lAG2xrHuddMoqrSrpHBPZ_lWGETRh Entries_0: _globalsign-domain-verification=8Je578rUxg5R2lAG2xrHuddMoqrSrpHBPZ_lWGETRh
amneal.com	TXT	IN	60	Txt: _globalsign-domain-verification=XTGVT_NFOeLPym-zasRpY9GSMpQ5T5aTLFhmdS2kuw Entries_0: _globalsign-domain-verification=XTGVT_NFOeLPym-zasRpY9GSMpQ5T5aTLFhmdS2kuw
amneal.com	TXT	IN	60	Txt: apple-domain-verification=4QUFLCzKq1m6VUlY Entries_0: apple-domain-verification=4QUFLCzKq1m6VUlY
amneal.com	TXT	IN	60	Txt: globalsign-domain-verification=T2rIu4sYTV4TYUExTRgWFk9ETNIpA00bdQ-wYDY8QQ Entries_0: globalsign-domain-verification=T2rIu4sYTV4TYUExTRgWFk9ETNIpA00bdQ-wYDY8QQ
amneal.com	TXT	IN	60	Txt: gsNbPgMZu80Jpj9h81JT9JhF/R2SvbKKsEd1FEV47730YW18aJ6w3+2GJXcktlf1nBuijS3lgnHYvMCzAIR7Mg== Entries_0: gsNbPgMZu80Jpj9h81JT9JhF/R2SvbKKsEd1FEV47730YW18aJ6w3+2GJXcktlf1nBuijS3lgnHYvMCzAIR7Mg==
amneal.com	TXT	IN	60	Txt: kRopHq6+IY7ISADplGfhohiTomhoptZ9RsRdpne7ayxOuPz56+pZSCOPWyOKSlgAg5iaEAxUGCPg1GY4Vzkajw== Entries_0: kRopHq6+IY7ISADplGfhohiTomhoptZ9RsRdpne7ayxOuPz56+pZSCOPWyOKSlgAg5iaEAxUGCPg1GY4Vzkajw==
amneal.com	TXT	IN	60	Txt: tg0tyzpf6yl1kwtz6nsfy9txggrp0l0j Entries_0: tg0tyzpf6yl1kwtz6nsfy9txggrp0l0j
amneal.com	TXT	IN	60	Txt: v=spf1 ip4:54.240.43.16 ip4:5.61.117.96/28 include:spf-003ba101.pphosted.com include:_spf.salesforce.com include:spf_c.oraclecloud.com include:nw027.com include:docebosaas.com include:40023361.spf10.hubspotemail.net ~all Entries_0: v=spf1 ip4:54.240.43.16 ip4:5.61.117.96/28 include:spf-003ba101.pphosted.com include:_spf.salesforce.com include:spf_c.oraclecloud.com include:nw027.com include:docebosaas.com include:40023361.spf10.hubspotemail.net ~all

Hosting and Whois Zone

IP	98.129.229.110
Domain infomation	Domain Name: AMNEAL.COM Registry Domain ID: 75890482_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2023-06-10T05:54:38Z Creation Date: 2001-08-10T03:24:52Z Registry Expiry Date: 2024-08-10T03:24:52Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: [email protected] Registrar Abuse Contact Phone: +1.8777228662 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-1382.AWSDNS-44.ORG Name Server: NS-145.AWSDNS-18.COM Name Server: NS-1745.AWSDNS-26.CO.UK Name Server: NS-805.AWSDNS-36.NET DNSSEC: unsigned URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/ >>> Last update of whois database: 2024-04-24T09:59:51Z <<< For more information on Whois status codes, please visit https://icann.org/epp NOTICE: The expiration date displayed in this record is the date the registrar's sponsorship of the domain name registration in the registry is currently set to expire. This date does not necessarily reflect the expiration date of the domain name registrant's agreement with the sponsoring registrar. Users may consult the sponsoring registrar's Whois database to view the registrar's reported date of expiration for this registration. TERMS OF USE: You are not authorized to access or query our Whois database through the use of electronic processes that are high-volume and automated except as reasonably necessary to register domain names or modify existing registrations; the Data in VeriSign Global Registry Services' ("VeriSign") Whois database is provided by VeriSign for information purposes only, and to assist persons in obtaining information about or related to a domain name registration record. VeriSign does not guarantee its accuracy. By submitting a Whois query, you agree to abide by the following terms of use: You agree that you may use this Data only for lawful purposes and that under no circumstances will you use this Data to: (1) allow, enable, or otherwise support the transmission of mass unsolicited, commercial advertising or solicitations via e-mail, telephone, or facsimile; or (2) enable high volume, automated, electronic processes that apply to VeriSign (or its computer systems). The compilation, repackaging, dissemination or other use of this Data is expressly prohibited without the prior written consent of VeriSign. You agree not to use electronic processes that are automated and high-volume to access or query the Whois database except as reasonably necessary to register domain names or modify existing registrations. VeriSign reserves the right to restrict your access to the Whois database in its sole discretion to ensure operational stability. VeriSign may restrict or terminate your access to the Whois database for failure to abide by these terms of use. VeriSign reserves the right to modify these terms at any time. The Registry database contains ONLY .COM, .NET, .EDU domains and Registrars.